查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1721575

消融設備市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Ablation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球消融設備市場價值為 110 億美元，預計到 2034 年將以 8.1% 的複合年成長率成長，達到 248 億美元。由於全球癌症和心血管疾病等慢性疾病負擔日益加重，消融設備的需求持續上升。隨著世界各地的醫療保健系統優先考慮能夠以更快的恢復時間提供目標結果的微創解決方案，消融技術已成為首選的治療方法。醫院和診所正積極採用這些設備，為患者提供比傳統手術更有效的替代方案。患者和醫療專業人員對能量治療益處的認知不斷提高，進一步推動了市場的發展。

消融設備市場 - IMG1

持續的技術進步，加上支持性監管框架，使得消融設備更容易取得且價格更實惠。政府和醫療機構也認知到消融技術在減少住院時間和整體治療成本方面的作用，這加速了其融入主流護理。此外，門診手術的增加和個人化醫療的推動為產品創新和針對患者的治療計劃開闢了新的途徑。隨著精準醫療需求的增加，製造商正在大力投資研發，將更智慧、更安全、更適應性的消融解決方案推向市場。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 110億美元
預測值 248億美元
複合年成長率 8.1%

消融設備是一種專門的醫療器械，旨在透過聚焦能量傳輸來去除或破壞異常組織。這些設備在提供精確、可控的治療方案的同時，對周圍健康組織的損害最小，並發揮關鍵作用。該市場擁有廣泛的技術，包括射頻、雷射/光、超音波、冷凍消融等，每種技術都根據臨床需求和患者情況具有獨特的優勢。

2024 年，射頻設備領域佔據全球消融設備市場的 49.2% 主導佔有率，預計未來幾年仍將保持這一領先地位。這項優勢很大程度上歸功於該技術在治療癌症和心律不整等慢性疾病方面日益廣泛的應用。射頻消融術（RFA）因其微創性和高治療效果而受到廣泛認可，成為醫生的首選。 RFA 技術的持續進步，包括更精確的定位和增強的安全性，正在進一步推動其應用。

消融設備廣泛應用於各種醫療應用，包括心臟病學、腫瘤學、婦科、泌尿科、眼科和整容手術。 2024 年，光是心臟病學領域就創造了 45 億美元的收入，這得益於老齡人口的成長和非侵入性心臟治療需求的不斷成長。先進影像技術支援的早期診斷使患者能夠及時接受治療，而強力的醫生建議則繼續增加城市和農村醫療保健環境中的手術量。

預計到 2034 年，美國消融設備市場規模將達到 89 億美元。美國 FDA 的快速核准流程以及優惠的醫療保險和私人保險公司報銷政策大大提高了患者的就醫機會，並鼓勵供應商擴大其治療範圍。

全球消融設備產業的主要參與者包括 CONMED Corporation、美敦力、波士頓科學公司、強生公司、全錄輝公司、奧林巴斯公司、Biosense Webster 公司、AngioDynamics 公司、雅培實驗室和瓦里安醫療系統公司。這些公司專注於透過合作、收購和推出脈衝場消融系統等下一代技術來實現策略性成長。透過與研究機構合作並投資先進的設備開發，他們旨在提供更安全、更有效的消融解決方案並加強其全球影響力。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 慢性病盛行率不斷上升
      • 消融設備的技術進步
      • 微創手術需求不斷成長
      • 老年人口基數不斷增加
    • 產業陷阱與挑戰
      • 消融手術風險高
      • 嚴格的法規核准
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 專利分析
  • 波特的分析
  • PESTEL分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按技術，2021 年至 2034 年

  • 主要趨勢
  • 射頻設備
  • 雷射/光消融
  • 超音波設備
  • 冷凍消融設備
  • 其他技術

第6章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 心臟病學
  • 腫瘤學
  • 眼科
  • 婦科
  • 泌尿科
  • 整容手術
  • 其他應用

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用途

第8章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 俄羅斯
    • 波蘭
    • 瑞士
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 泰國
    • 印尼
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 以色列

第9章：公司簡介

  • Abbott Laboratories
  • Alcon Laboratories
  • Angiodynamics
  • Atricure
  • Bausch & Lomb
  • Biotronik
  • Boston Scientific
  • CONMED
  • Elekta
  • Ethicon
  • Medtronic
  • Olympus
  • Varian
簡介目錄
Product Code: 3419

The Global Ablation Devices Market was valued at USD 11 billion in 2024 and is estimated to grow at a CAGR of 8.1% to reach USD 24.8 billion by 2034. The demand for ablation devices continues to rise, fueled by the increasing global burden of chronic diseases like cancer and cardiovascular conditions. As healthcare systems worldwide prioritize minimally invasive solutions that deliver targeted results with faster recovery times, ablation technology has emerged as a go-to treatment method. Hospitals and clinics are actively adopting these devices to offer patients more efficient alternatives to traditional surgery. The growing awareness among patients and medical professionals about the benefits of energy-based treatments has further pushed the market forward.

Ablation Devices Market - IMG1

Ongoing technological advancements, combined with supportive regulatory frameworks, are making ablation devices more accessible and affordable. Governments and healthcare bodies are also recognizing the role of ablation technologies in reducing hospital stays and overall treatment costs, which is accelerating their integration into mainstream care. Additionally, the rise in outpatient procedures and the push toward personalized healthcare have opened new avenues for product innovation and patient-specific treatment planning. As the demand for precision medicine increases, manufacturers are investing heavily in R&D to bring smarter, safer, and more adaptable ablation solutions to market.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$11 Billion
Forecast Value$24.8 Billion
CAGR8.1%

Ablation devices are specialized medical instruments designed to remove or destroy abnormal tissues through focused energy delivery. These devices play a critical role in offering precise and controlled treatment options with minimal damage to surrounding healthy tissue. The market features a broad range of technologies, including radiofrequency, laser/light, ultrasound, cryoablation, and more-each with unique advantages based on clinical needs and patient profiles.

The radiofrequency devices segment held a dominant 49.2% share of the global ablation devices market in 2024 and is expected to maintain this lead in the years ahead. This stronghold is largely attributed to the technology's growing use in treating chronic conditions like cancer and cardiac arrhythmias. Radiofrequency ablation (RFA) is widely recognized for its minimally invasive nature and high treatment efficacy, making it a preferred choice among physicians. Continued advancements in RFA technology, including more precise targeting and enhanced safety profiles, are further driving adoption.

Ablation devices are widely used in various medical applications, including cardiology, oncology, gynecology, urology, ophthalmology, and cosmetic surgery. In 2024, the cardiology segment alone generated USD 4.5 billion, driven by a rising elderly population and the growing demand for non-invasive cardiac treatments. Early diagnosis supported by advanced imaging technologies has empowered patients to pursue timely treatment, while strong physician recommendations continue to boost procedure volumes in both urban and rural healthcare settings.

The U.S. Ablation Devices Market is projected to reach USD 8.9 billion by 2034. The U.S. FDA's fast-track approval processes and favorable Medicare and private insurer reimbursement policies have significantly enhanced patient access and encouraged providers to broaden their treatment offerings.

Key players in the global ablation devices industry include CONMED Corporation, Medtronic, Boston Scientific Corporation, Johnson & Johnson, Smith & Nephew plc, Olympus Corporation, Biosense Webster, Inc., AngioDynamics, Inc., Abbott Laboratories, and Varian Medical Systems Inc. These companies are focused on strategic growth through partnerships, acquisitions, and the launch of next-gen technologies like pulsed-field ablation systems. By collaborating with research institutions and investing in advanced device development, they aim to deliver safer, more effective ablation solutions and strengthen their global footprint.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° Synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in ablation devices
      • 3.2.1.3 Rising demand for minimally invasive procedures
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High risk associated with ablation procedures
      • 3.2.2.2 Stringent regulatory approvals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Patent analysis
  • 3.9 Porter’s analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Radiofrequency devices
  • 5.3 Laser/light ablation
  • 5.4 Ultrasound devices
  • 5.5 Cryoablation devices
  • 5.6 Other technologies

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiology
  • 6.3 Oncology
  • 6.4 Ophthalmology
  • 6.5 Gynecology
  • 6.6 Urology
  • 6.7 Cosmetic surgery
  • 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Poland
    • 8.3.8 Switzerland
    • 8.3.9 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Thailand
    • 8.4.7 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Columbia
    • 8.5.5 Chile
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Alcon Laboratories
  • 9.3 Angiodynamics
  • 9.4 Atricure
  • 9.5 Bausch & Lomb
  • 9.6 Biotronik
  • 9.7 Boston Scientific
  • 9.8 CONMED
  • 9.9 Elekta
  • 9.10 Ethicon
  • 9.11 Medtronic
  • 9.12 Olympus
  • 9.13 Varian